News

British Grammy-nominated singer Jessie J has been diagnosed with early-stage breast cancer at the age of 37. "Cancer sucks in any form, but I'm holding onto the word 'early,'" Jessie told her nearly ...
At the heart of innovation is T-win®, a groundbreaking vaccine platform that could change how we treat cancer.
Detection of cancer before a clinical diagnosis could give patients and caregivers more time for intervention and may lead to ...
The researchers found that cervical mucus from Pap smears has a higher cell-free DNA yield than plasma in endometrial cancer cases.
The MHRA has approved aumolertinib for adult patients with non-small cell lung cancer (NSCLC), following a groundbreaking ...
Lung cancer is the malignant tumor with the highest incidence and mortality rate in the world. With the in-depth research of ...
Switching to camizestrant, a next-generation oral SERD, significantly prolongs progression-free survival and maintains ...
(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, was host to the Oral Abstract Session: Genitourinary Cancer—Prostate, Testicular, and Penile.
Losing the Y chromosome seems to make cancer cells more aggressive in men and the phenomenon may even spread between cells.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Researchers are trying to better understand how co-mutations and PD-L1 expression impact response to single-agent KRAS G12C ...
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...